carbazochrome has been researched along with Chronic Disease in 1 studies
carbazochrome: a hemostatic which increases capillary resistance & activates platelet factors, Note: Adona is a multimeaning tradename
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the effect of carbazochrome sodium sulfonate, an agent that reduces capillary permeability, on refractory chronic prostatitis." | 9.19 | Effect of carbazochrome sodium sulfonate on refractory chronic prostatitis. ( Ashitomi, K; Kadekawa, K; Nishijima, S; Noto, H; Oh-oka, H; Sugaya, K; Umeyama, T; Yamada, T, 2014) |
| "To study the effect of carbazochrome sodium sulfonate, an agent that reduces capillary permeability, on refractory chronic prostatitis." | 5.19 | Effect of carbazochrome sodium sulfonate on refractory chronic prostatitis. ( Ashitomi, K; Kadekawa, K; Nishijima, S; Noto, H; Oh-oka, H; Sugaya, K; Umeyama, T; Yamada, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh-oka, H | 1 |
| Yamada, T | 1 |
| Noto, H | 1 |
| Umeyama, T | 1 |
| Kadekawa, K | 1 |
| Ashitomi, K | 1 |
| Nishijima, S | 1 |
| Sugaya, K | 1 |
1 trial available for carbazochrome and Chronic Disease
| Article | Year |
|---|---|
Effect of carbazochrome sodium sulfonate on refractory chronic prostatitis.
Topics: Adrenochrome; Aged; Chronic Disease; Hemostatics; Humans; Male; Middle Aged; Prostatitis; Treatment | 2014 |